F. Carini et al., Tachykinin NK2 receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study, BR J PHARM, 133(7), 2001, pp. 1107-1113
1 In the gastrointestinal tract, tachykinin NK2 receptors are localized bot
h on smooth muscle and nerve fibres. NK2 receptor antagonists reduce exagge
rated intestinal motility in various diarrhoea models but the site of actio
n contributing to this effect is unknown. In this study we investigated the
effects of atropine (1.4 mu mol kg(-1), i.v.), hexamethonium (13.5 mu mol
kg(-1), i.v.), and nepadutant (0.1 mu mol kg(-1), i.v.), a selective tachyk
inin NK2 receptor antagonist, on distension (0.5 and 1 ml)-, or irritation
(acetic acid, 0.5 ml of 7.5% v v(-1))-induced motility in the rat distal co
lon in vivo. The effects of atropine, hexamethonium or N-(' ())-nitro-L-arg
ininemethylester (L-NAME, 1.85 mu mol kg(-1), i.v.) on [beta Ala(8)]NKA(4-1
0) (10 nmol kg(-1), i.v.)-induced colonic contractions were also investigat
ed.
2 When the colonic balloon was filled with a subthreshold volume (0.5 ml),
the intraluminal instillation of acetic acid triggered a high-amplitude pha
sic colonic motility which was partially reduced by nepadutant and suppress
ed by either hexamethonium or atropine. Filling of the balloon with 1 ml ev
oked reflex (hexamethonium-sensitive), atropine-sensitive phasic colonic mo
tility: nepadutant had no significant effect on the distension-evoked motil
ity.
3 Neither hexamethonium nor atropine significantly reduced [beta Ala(8)]NKA
(4-10)-induced colonic contractions, whereas nepadutant suppressed them. Fo
llowing L-NAME pretreatment, [beta Ala(8)]NKA(4-10)-induced colonic contrac
tions were inhibited by both atropine and hexamethonium. In hexamethonium-p
retreated animals, an atropine-sensitive component of [beta Ala(8)]NKA(4-10
)-induced colonic contractions was also evident.
4 These results indicate that the application of irritants onto the colonic
mucosa induces the release of endogenous tachykinins which enhance excitat
ory cholinergic mechanisms through the stimulation of NK2 receptors.